This pharmaceutical company specializes in the development, manufacturing, and distribution of a wide range of healthcare products. They have a strong focus on affordability and accessibility, targeting therapeutic areas such as gastrointestinal, cardiovascular, women's health, and respiratory conditions. Their product portfolio includes APIs and finished dosage formulations (FDFs), with over 50 ANDAs and 25 DMFs available. They boast a WHO GMP certified manufacturing facility with a capacity of up to 450 tons per annum, serving clients across the globe in regions like North America, Europe, Asia, and Oceania. Their R&D efforts are dedicated to developing complex molecules and biosimilars, showcasing their commitment to innovation within the pharmaceutical industry.

​Established in 2007, this Manufacturer is a CTD dossier owner and manufacturer based in Mumbai, India. With a team of 11–50 employees, it operates two WHO-GMP certified facilities in Baddi, Himachal Pradesh, specializing in the production of tablets, capsules, and injectable formulations. As a GMP manufacturer, it ensures adherence to international quality standards. The Manufacturer's products are distributed across more than 50 countries and regions worldwide. Its commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.